Clinical Trial Update: To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic comparison of Traclear 62.5 mg tablets and HGP1206 125 mg in healthy male volunteers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• HGP1206
• Traclear

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED